Illinois SB3550 establishes a pilot program for long-acting injectable medications for substance use disorders in correctional facilities.
Illinois SB3550 amends the Unified Code of Corrections to mandate the Department of Corrections to implement a pilot program starting January 1, 2027. This program aims to evaluate the effectiveness of long-acting injectable medications for substance use disorders among individuals in custody. The pilot program must include at least 4,000 administrations of these medications and will be expanded to additional facilities as deemed appropriate by the Director. The Department must report on the program's effectiveness to the General Assembly by January 1, 2028.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.